Chemistry of 3,4`-Bipyrazoles
Kamal M. Dawood, Ashraf A. Abbas Abstract
All the possible synthetic routes to the 3,4`-bipyrazole systems were thoroughly reported. Such synthetic platforms include: cyclocondensation and 1,3-dipolar cycloaddition reactions. Many of the reported 3,4`-bipyrazoles have potent applications in the field of pharmaceutical and material science.
Keywords: 1,3-dipolar cycloaddition, 3,4`-bipyrazoles, 3,4`-bipyrazolines, Cross-coupling, Cyclocondensation, Pyrazolylhydrazones.
1. Introduction
Various 3,4`-bipyrazoles ring skeletons were reported in the literature. They are composed of either two aromatic pyrazole units or 4-pyrazolyl attached with pyrazoline at C-3 or 4-pyrazolinyl attached to pyrazole at C-3. As a result, there will be the aromatic 3,4`-bipyrazole skeleton or partially aromatic pyrazolylpyrazoline skeleton. The two pyrazole unites are connected directly with a sigma bond between the two units. A number of tautomeric forms can be constructed, as shown in Scheme (1). Synthesis of such 3,4`-bipyrazole skeletons was achieved via several synthetic routes as outlined in Scheme (2). Such synthetic routes include: 1) cyclocondensation of an activated 4-pyrazole ring having chalcones or 1,3-dicarbonyl functions with hydrazines; 2) 1,3-dipolar cycloaddition of pyrazolylhydrazones with activated olefins or acetylenes; 3) 1,3-dipolar cycloaddition of nitrilimines with bis-olefines with nitrilimines or diazo-alkanes; and 4) C-C cross coupling reactions of pyrazolylboronic acids with halopyrazoles or pyrazoles themselves via C-H activation using palladium catalysts.
The fully aromatic 3,4`-bipyrazoles and their partially aromatic ones (pyrazolylpyrazolines) are potent inhibitory active heterocycles with significant biological potentialities. The 3,4`-bipyrazole derivatives were also considered to have anticancer [1-5], antimicrobial [6-12], anti-inflammatory [13-19], antioxidant [20], antitubercular [21-23] and antimalarial activities [24]. They
were found to be effective enzyme inhibitors against carbonic anhydrase inhibitory activity [25], human Tropomyosin-related kinase A (TrkA) [26-30], and Janus kinase (JAK1/JAK2) [31]. 3,4`-Bipyrazole-based metal coordination complexes were reported to display remarkable pharmaceuticals applications. For example, gold(III) and iridium(II) complexes of 3,4`-bipyrazoles were useful as anticancer agents [4, 5]. In addition, the palladium(II) and platinum(II) complexes of 3,4`-bipyrazoles were found to have excellent antibacterial and antifungal activities [6, 32].
Scheme (1)) The possible direct connected 3,4`-bipyrazole derivatives
Scheme (2)) The possible synthetic routes to 3,4`-bipyrazoles systems
2. Synthesis of 3,4`-bipyrazole derivatives
2.1. From 1,3-dipolar Cycloaddition Reactions
1,3-Dipolar cycloaddition of 4-pyrazolylformylhydrazone 1 with some activated dipolarophiles such as dimethyl fumarate 3 and ethyl 3-phenylpropiolate 5 under solvent-free conditions using microwave irradiation technique resulted in the construction of the corresponding 3,4`-bipyrazoles 4 and 6, respectively. Similar reaction of the hydrazone 1 with ethyl propiolate 7 under microwave heating at 170 °C afforded a mixture of the 3,4`-bipyrazole derivatives 8 and 9 (Scheme 3). The 1H NMR analysis of structure 9 presented the following data: Ύ 5 1.37 (t, J = 7.1 Hz, 3H, CH3), 4.33 (q, J = 7.1 Hz, 2H, CH2), 7.35 (s, 1H, H-5'), 7.28-7.48 (m, 8H, ArH`s) 7.64 (d, J = 8.6 Hz, 2H, o-H 1-Ph), 8.17 (s, 1H, H-3), 8.40 (s, 1H, H-5). Mechanistically, the regioselective cycloaddition process proceeded via the addition of the dipolarophiles 3 and 5 to the dipolar intermediate 2 followed by aromatization ...